Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Inclusion in HIV Vaccine Trials: A Critical Need

Post vaccination decline in pneumonia: 10 years of study shows

Understanding complexes within the SARS-CoV-2 proteome

Inclusion in HIV Vaccine Trials: A Critical Need
  • BiotechToday
  • World

Inclusion in HIV Vaccine Trials: A Critical Need

BioTech Today July 19, 2021July 18, 2021

Agrima Bhatt, Rajasthan University

HIV has been present in our society for more than 30 years, from Central Africa to the USA and around the world. Viruses, as we can observe from 2021, are hard to combat! From the 1700s till today, have we progressed in society to include everyone without prejudice. From this crucial bit to the question of HIV. Is it still an epidemic? Let’s find more!

It is unfortunate that over a million people still face death every year from HIV (as reported by WHO). Most of the cases that are suffering from HIV find themselves in a serious predicament, occurring due to various reasons. One such reason is either the delay or absence of treatment. This takes place as people become marginalized from society and face immense guilt and prejudice, even after about 40 years since the first case appeared.

HIV first appeared in Africa in the late 1800s. It is known to come from a type of chimpanzee in Central Africa. From there on, it continues to rage in the world from the mid-1970s in the USA till now becoming a major health concern on a global scale. 2019 statistics report that about 38 million people are currently carrying HIV in their bloodstream including 1.8 million children.

The Thai Case 

Since 2010, there has been a surge of HIV diagnoses in men who have sex with men (MSM). About 11 percent of transgenic women (TGW) were also found to be prevalent with this virus as compared to 1.1 percent in all Thai adults. According to the Asian Epidemic Model, over half of HIV infections in the next decade or so are threatening the MSM population in Thailand. 

Since the uptake of traditional prevention methods has been low, such as oral PrEP, novel preventive methods have come out in research to stop this surge infection. Oral PrEP stands for Oral pre-exposure prophylaxis is the administration of antiviral drugs to an HIV-negative person to decrease his/her susceptibility to the virus. Such methods are not very popular in Thailand due to the expenditure and time expense. New methods like prevention vaccines have become quite popular in the research and development sector and scientists are looking into factors concerning “seroconversion”.

Vaccine Trials and Investigation:

However, vaccine trials account for three main things to be considered successful. One is the willingness of participants, the second is gaining access to the HIV population, and the last remains the retention rate over a while. Over the 18-month trial period, 53 HIV infections were reported, equal in both transgenic women and MSM. An excellent retention rate of 93.4% was found among participants which are crucial for vaccine studies. Among the infected persons, 18–21 years old showed the highest risk of seroconversion i.e., the antibodies start developing in an HIV-positive until detectable range. 

Significance of the study:

Such vaccine trials become crucial not only for the development but also to encourage people to come out and educate themselves. This study was found to be significant to educate the target population on HIV and its prevention methods. Such clinical trials encourage the inclusion of all people irrespective of gender or sexual orientation in taking preventive measures against HIV. This study highlighted the importance of awareness and education towards HIV and its preventive measures. Through this research, the importance of PrEP and clinical trials among the youth was found out to be the need of the hour.

Also read: Mutant Genes Acting aid in Inter-Kingdom Genetic Transfer

References:

  1. Wansom, T., Muangnoicharoen, S., Nitayaphan, S., Kitsiripornchai, S., Crowell, T. A., Francisco, L., Gilbert, P., Rwakasyaguri, D., Dhitavat, J., Li, Q., King, D., Robb, M. L., Smith, K., Heger, E. A., Akapirat, S., Pitisuttithum, P., O’Connell, R. J., & Vasan, S. (2021). Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand. EClinicalMedicine, 0(0). https://doi.org/10.1016/j.eclinm.2021.101033 
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Author’s info:

Agrima Bhatt is an undergraduate student studying BSc. Biotechnology in Jaipur, Rajasthan. She is a science and research enthusiast who also loves to write articles and short snippets.

Some of her published articles at BioXone are:

  1. https://bioxone.in/news/worldnews/molecular-mechanisms-underlying-virescent-mutation-in-cotton/
  2. https://bioxone.in/news/worldnews/multi-angle-projection-microscope-a-novel-imaging-technique/
  3. https://bioxone.in/news/worldnews/scientists-develop-novel-cholera-vaccine-from-rice-grains/
  4. https://bioxone.in/news/worldnews/ai-predicts-the-relation-between-viruses-and-mammals/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Antibodies Clinical trial HIV inclusion MSM PrEP prevention seroconversion transgenic women VACCINE

One thought on “Inclusion in HIV Vaccine Trials: A Critical Need”

  1. Pingback: Zinc Sparks associated with Fertilization - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Understanding complexes within the SARS-CoV-2 proteome

BioTech Today July 19, 2021

Soumya Shraddhya Paul, Amity University, Noida COVID-19 pandemic has caused a lot of turmoil all around the world. According to WHO nearly 164 million people were infected worldwide out of which 3.4 million people lost their lives worldwide. Now, as we know COVID 19 is a respiratory disease caused by SARS-C0V-2 which belongs to the […]

complexes

Related Post

  • BiotechToday
  • World

Can blood clots be ‘drilled’ open?

bioxone January 13, 2021January 13, 2021

Shrayana Ghosh, Amity University Kolkata A new technique for removing extremely tough blood clots has been developed by researchers, using engineered nanodroplets and an ultrasound “drill” to break down the clots from within. The approach has not gone through clinical trials yet, promising results have been shown by in vitro testing. Primarily, the new technique […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Niche theory and modeling- the future of microbial ecology

BioTech Today June 18, 2021June 17, 2021

Deivayanai V.C, Rajalakshmi Engineering College Niche theory and modeling define the environment required by an organism for its metabolism and reproduction. The animals and plants’ niches are well studied and characterized but microbial niches are comparatively not much well explored and classified. Many microbial niches cause harmful diseases such as pathogenic diseases, valley fever, etc. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Alcohol consumption: A devastating path to cancer

BioTech Today July 20, 2021July 21, 2021

Saptaparna Dasgupta, Bennett University Studies have stated that alcohol consumption is linked to the induction of several cancers. Global estimates reveal that in the year 2020, 4.1% of the reported cancer cases were from alcohol consumption. Heavy drinking (>60 g per day) is the largest cause of cancer, majorly amongst male patients. Researchers conducted a […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy